Evidence map›Paper›PMID 40452667›Full record

ReviewCureus2025

Exploring Risk Factors and Patterns in Uncommon Recurrences of Varicella-Zoster Reactivation: A Review of Case Reports.

Kiarra Krulikowski, Brittany Shectman, Dania Ilyas, Suzanne I Riskin

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kiarra KrulikowskiDepartment of Foundational Sciences, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Clearwater, USA.
Brittany ShectmanDepartment of Foundational Sciences, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Clearwater, USA.
Dania IlyasDepartment of Foundational Sciences, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Clearwater, USA.
Suzanne I RiskinDepartment of Foundational Sciences, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Clearwater, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Varicella-zoster virus (VZV) causes chickenpox and then establishes latency in the autonomic ganglia. Reactivation of the virus, known as herpes zoster or shingles, manifests as a unilateral, vesicular rash localized within one dermatome accompanied by pain and pruritus. While the classic rash resolves within three weeks, older or immunocompromised individuals may experience prolonged symptoms, increased vesicle number, and complications such as post-herpetic neuralgia. Although the classic manifestations of VZV are well known, more cases are appearing with an atypical presentation. We highlight eight reports of unusual presentations describing confirmed cases of VZV that become reactivated and note a wide range of ages, with half over 70 years of age and half under 40 years of age, two including children. Unusual presentations include zoster sine herpete, vocal fold paralysis due to vagal nerve involvement, and encephalitis with massive pulmonary emboli in a previously healthy 37-year-old woman. One case features a child who developed shingles from the vaccine strain of VZV. Diagnostic delays occurred in all cases due to the atypical nature of the presentations, often resulting in initial misdiagnoses and inappropriate treatments such as antibiotics or corticosteroids. Despite eventual antiviral therapy, two patients experienced incomplete recovery, suffering from persistent neuropathic pain or muscle atrophy. These cases emphasize the variability in VZV presentations, the importance of timely diagnosis, and the need for greater clinical awareness to prevent delayed treatment and adverse outcomes.

Indexed as

atypical presentationherpes zosterimmunocompromisedpost herpetic neuralgiareactivationrisk factorsshinglesvaricella reactivationvesicular rashvzv vaccination

Identifiers

PMID40452667
PMCPMC12125962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.